New York City Nurses And Hospitals Dig In During Strike’s Second Week

In this week’s edition of InnovationRx, we look at why Yann LeCun’s AI startup is focused on healthcare, Epic’s new predictive tools, and more.

The Short-Sighted, $27 Billion U.S. EV Retreat

This week’s Current Climate newsletter also looks at Brightline’s rising bullet train costs and how Ecolab is solving the data center water problem.

Investors Put More Than $55 Billion Behind Space Startups Last Year

In this week’s edition of The Prototype, we look at the booming space industry, better space weather forecasts, the first medical evacuation from space and more.

Inside The J.P. Morgan Healthcare Extravaganza

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and Lilly’s $1 billion AI venture, and more.

The U.S. Goes Rogue On The Climate Fight

This week’s Current Climate newsletter also looks at the AI boom’s water problem and stabilized funding for the California High-Speed Rail project.

Nvidia And This Bill Gates-Backed Startup Are Building Fusion Power With AI

In this week’s edition of The Prototype, we look at building a virtual fusion power plant, a major quantum breakthrough, AI for drug discovery and more.

Measles And Flu Hit New Highs As Trump Administration Hammers Vaccines

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, Wegovy’s weight-loss pill, and more.

Good Day Sunshine: Solar’s Relentless Rise

This week’s Current Climate newsletter also looks at Elon Musk’s year of big blunders and payday bonanzas and some progress for green hydrogen

The Biggest Technological Breakthroughs Of 2025

In this week’s edition of The Prototype we look at the biggest tech breakthroughs of 2025–and the year’s best music.

From Ford To Tesla, Big Electric Pickups Are A Tough Sell

This week’s Current Climate newsletter also looks at a new approach to underground hydrogen and why Tesla is facing a California sales suspension